Sunscreen Innovation Act Starts Clock Ticking On FDA Review Of TEAs
This article was originally published in The Tan Sheet
Congress passes legislation to provide an alternative process for reviewing UV filters to be added to the OTC drug sunscreen monograph. The bill’s passing during Congress’ lame duck session reflects not only bipartisan support, but also lobbying by the personal care product industry and consumer health advocates to impose deadlines on FDA for long-sought changes to the sunscreen monograph.
You may also be interested in...
Sanofi eyes $1bn top line growth from OTC switches of ED drug Cialis and flu drug Tamiflu after they launch by 2026, says CEO Paul Hudson. Like switch consultants, though, he acknowledges the high bar for approval moving additional Rx ingredients to OTC.
FDA warns OHM Pharma for promoting topical formula containing homeopathic ingredients as teething product for infants. The firm also warned about drug and supplements GMP violations and was an easy target for FDA following release of draft guidance outlining its enforcement priorities.
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.